Fulcrum Therapeutics Appoints Alex C. Sapir Chief Executive Officer

Go back to Fulcrum Therapeutics Appoints Alex C. Sapir Chief Executive Officer
(NASDAQ: FULC) Delayed: 3.85 -0.06 (1.53%)
Previous Close $3.91    52 Week High
Open $3.88    52 Week Low
Day High $3.91    P/E N/A 
Day Low $3.81    EPS
Volume 1,197,580